Phathom Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Phathom Pharmaceuticals

Access the complete profile.

Phathom Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	100 Campus Drive, Suite 102 Florham Park, NJ 07932

Note: Revenues for privately held companies are statistical evaluations.


Phathom Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Phathom Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Phathom Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Phathom Pharmaceuticals Annual Revenue and Growth Rate

Phathom Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Phathom Pharmaceuticals's revenues are gauged from an analysis of company filings.

Phathom Pharmaceuticals's Income Statement (based on Industry Averages)

Phathom Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Phathom Pharmaceuticals is developing and marketing. Phathom Pharmaceuticals doesn't have any recent trademark applications, indicating Phathom Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DURMYGTI Pharmaceutical preparations for the treatment of gastrointestinal related diseases, disorders and infections	03/15/2022
VONZYK Pharmaceutical preparations for the treatment of gastrointestinal related diseases, disorders and infections	01/12/2022
ZEPCABA Pharmaceutical preparations for the treatment of gastrointestinal related diseases, disorders and infections	01/12/2022

See all trademarks and details in the Full Report.

Market Share of Phathom Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Phathom Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Phathom Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVARTIS	East Hanover, NJ	100
CELGENE	Summit, NJ	14
ALVOGEN GROUP	Morristown, NJ	13
EXELTIS USA	Florham Park, NJ	2
PHATHOM PHARMACEUTICALS	Florham Park, NJ	1
PHARMAHEALTH LABS	Morristown, NJ	1

Future Competition: Phathom Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Phathom Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)